U.S. Markets open in 2 hrs 24 mins
  • S&P Futures

    3,621.50
    -15.00 (-0.41%)
     
  • Dow Futures

    29,685.00
    -189.00 (-0.63%)
     
  • Nasdaq Futures

    12,260.00
    +2.50 (+0.02%)
     
  • Russell 2000 Futures

    1,839.80
    -13.20 (-0.71%)
     
  • Crude Oil

    44.88
    -0.65 (-1.43%)
     
  • Gold

    1,769.20
    -12.70 (-0.71%)
     
  • Silver

    22.25
    -0.39 (-1.72%)
     
  • EUR/USD

    1.1989
    +0.0019 (+0.1559%)
     
  • 10-Yr Bond

    0.8420
    0.0000 (0.00%)
     
  • Vix

    22.36
    +1.11 (+5.22%)
     
  • GBP/USD

    1.3353
    +0.0039 (+0.2938%)
     
  • USD/JPY

    104.0640
    -0.0210 (-0.0202%)
     
  • BTC-USD

    18,622.74
    +271.30 (+1.48%)
     
  • CMC Crypto 200

    366.33
    +28.83 (+8.54%)
     
  • FTSE 100

    6,360.08
    -7.50 (-0.12%)
     
  • Nikkei 225

    26,433.62
    -211.09 (-0.79%)
     

Collegium Pharmaceutical: 3Q Earnings Snapshot

·1 min read

STOUGHTON, Mass. (AP) _ Collegium Pharmaceutical Inc. (COLL) on Thursday reported third-quarter net income of $11.3 million, after reporting a loss in the same period a year earlier.

The Stoughton, Massachusetts-based company said it had net income of 32 cents per share.

The results topped Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for earnings of 23 cents per share.

The specialty pharmaceutical company posted revenue of $79.2 million in the period, also surpassing Street forecasts. Five analysts surveyed by Zacks expected $77.9 million.

Collegium Pharmaceutical shares have fallen roughly 3% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $19.98, a climb of 46% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on COLL at https://www.zacks.com/ap/COLL